Management Change/Compensation (Form 8-K)

On August 1, 2021, Agios Pharmaceuticals, Inc. (the 'Company') appointed T.J. Washburn, senior director, corporate accounting of the Company, to serve as the Company's principal accounting officer. Mr. Washburn, age 40, has nearly 20 years of technical accounting, financial reporting and corporate accounting experience, spending the last 4 years in positions of increasing responsibility at the Company. Prior to joining the Company, Mr. Washburn served in financial and corporate accounting roles at Ernst & Young, Cubist Pharmaceuticals (prior to its acquisition by Merck & Co.), Raytheon, Rue La La and Pricewaterhouse Coopers. Mr. Washburn is a certified public accountant, and obtained his bachelor of science degree in business administration from Babson College.